NASD · Healthcare · Medical Devices · USA
Establishment Labs Holdings Inc is a mid cap company (market value between $2 billion and $10 billion) in the Medical Devices industry.
Establishment Labs is a medical technology company that develops and sells silicone gel-filled breast implants under the Motiva brand for aesthetic augmentation and reconstruction. The product portfolio features proprietary technologies such as SmoothSilk surface treatment and Qid RFID identification. Motiva Implants are distributed globally through exclusive distributors and direct sales channels.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Establishment Labs Holdings Inc stock.
Overvalued: intrinsic value $8.40 per share, market price $69.51, margin of safety -727.5% (as of 2026-11-17).
A 1.6x revenue multiple, discounted for its losses, values the shares at $8.40; the price of $69.51 is 727% above that value.
17 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
54 more in this industry show a wider margin of safety.
ESTA is overvalued (as of the 2026-11-17 close). A 1.6x revenue multiple, discounted for its losses, values the shares at $8.40; the price of $69.51 is 727% above that value.
$8.40 per share (as of the 2026-11-17 close), against a market price of $69.51. That is a margin of safety of -727.5%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.